WithdrawnNot applicableNCT00733252

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

RATIONALE: Diagnostic procedures, such as optical coherence tomography, may help find and diagnose lung cancer or precancerous cells. PURPOSE: This phase I trial is studying how well optical coherence tomography of the airway works in detecting abnormal cells in patients undergoing surgery for lung cancer or lung disease.

Checked against the public recordLast updated Oct 2, 2015 · Source: ClinicalTrials.gov

StatusWithdrawn
PhaseNot applicable
U.S. locations1
SponsorCase Comprehensive Cancer Center
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Case Comprehensive Cancer Center
Interventions being studied
Procedure: bronchoscopic and lung imaging studies; Procedure: diagnostic bronchoscopy; Procedure: histopathologic examination; Procedure: optical coherence tomography
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type
Treatment approach
03
Public criteria

Who may be able to participate

DISEASE CHARACTERISTICS: * Undergoing pneumonectomy or lobectomy for malignant or benign lung processes PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer CenterCleveland, Ohio

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 2, 2015. Always confirm current availability with the study team.

View original record ↗